Library / regulatory-reference
Sweden: Medical Products Agency (Lakemedelsverket)
Audience: administrators-policy, researchers-scientists ยท Review state: published
The national authority
The Medical Products Agency, known in Swedish as Lakemedelsverket, is Sweden's national regulatory authority for medicines and medical devices.
Sweden's market sits inside the European single market, and the agency works within the European regulatory network while also supporting international regulatory capacity-building programs.
How products enter the market
Medicines require marketing authorization through national or European procedures after evaluation of quality, safety and efficacy, and establishments are licensed and inspected by the agency.
Post-market work includes safety monitoring within the European alert network, with Sweden's national health-data registers giving its pharmacoepidemiology research unusual strength.
Regional and international role
The agency is a senior member of the European regulatory network, and its international training programs for regulators from lower-income countries are a recognized contribution to global regulatory capacity.
Its register-based safety research is cited internationally as a model for using national data to monitor medicines.
Using this profile
The agency publishes regulations, registers and alerts in Swedish, with English material, through its official portal, which is the primary source for current rules and listed in this profile's internal reference record.
For cross-country comparison: Sweden illustrates the data-rich member state: regulation informed by national registers, plus an export of regulatory training.
Limitations
Educational profile of a national regulatory system, current as of drafting. It simplifies routes and classes and is not legal, regulatory, or clinical advice. Filing and compliance decisions must be confirmed against the authority's current published rules and, where needed, professional regulatory counsel.